Skip to content
SlotNetwork

Individuals Stopping Slimming Medications Regain Pounds at a Quadrupled Rate Than People Using Diet and Exercise

Illustration of pharmaceutical injection and scale
Weight management involves long-term strategies.

A recent study reveals that people who discontinue new slimming jabs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who end conventional diet and exercise programs.

Research printed in a leading medical journal shows that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying these drugs need to be informed of the danger of rapid rebound weight gain when the therapy concludes," warns expert Dr. Susan Jebb.

This pace of regain means a return to starting weight within about 18 months.

Weighing Approaches

The research, which reviewed dozens of studies involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.

The team emphasize that individuals who shed pounds through dieting generally have a more gradual weight regain—approximately 0.1 kg a month—post-intervention.

Understanding the Rapid Regain

Experts believe the way of the drugs is key to understanding the heightened rebound.

GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate appetite.

"Artificially providing the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement leads to appetite is uncontrolled, making excessive eating much more probable."

A Lifelong Disease?

The NHS recommend the injections for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.

Professionals contend that, given the significant potential of relapse, the therapy might need to be long-term.

This opinion is supported by pharmaceutical companies, who note that the results "emphasize the long-term character of excess weight," similar to managing diseases like high blood pressure.

User Experiences

People who have stopped the jabs explain a powerful resurgence of hunger.

"It felt as if a switch activating and you become ravenous," recalled an individual.

This challenge is compounded if users have not established sustainable lifestyle or habit modifications during treatment.

Significant Interest

Figures show that millions of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.

  • Adoption is more common among women than men.
  • The 40s and 50s age group shows the highest usage rates.
  • Many access the medications through private healthcare rather than the NHS.

Finally, clinicians stress that while the jabs are potent agents for shedding pounds, they are not a standalone solution and long-term success hinges on ongoing lifestyle support.

About the author

John Sandoval

A seasoned gaming analyst with over a decade of experience in reviewing online casinos and slot games across Canada.

SlotNetwork

Type to search articles.